Dr. Ismael Idris Yussuf, MD

Dr. Yussuf practices at Cedar Hill Regional Medical Center in Washington, District of Columbia.

Dr. Yussuf's NPI, 1770747032, was assigned on July 16, 2008. Dr. Yussuf holds Virginia license 0101255853.

Dr. Yussuf's primary practice is Cedar Hill Regional Medical Center, at 1200 Pecan St Se, Washington, DC 20032 in District Of Columbia County. The practice phone is (804) 237-7129.

Dr. Yussuf's primary practice is Cedar Hill Regional Medical Center in Washington, District of Columbia. Dr. Yussuf is also affiliated with The George Washington University Hospital. The medical group on file is Sentara Medical Group. Dmand AI also links Dr. Yussuf to 9 more medical groups, 8 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yussuf practices, 10 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Yussuf's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Yussuf's licenses on file in 2 states: Virginia and Wisconsin.

CMS data shows 1,106 Medicare services from Dr. Yussuf across 6 procedure codes in 2024, for 247 Medicare patients. Medicare paid $145,708 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 247 Medicare patients who saw Dr. Yussuf in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 77% are also on Medicaid. Their average risk score is 4.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yussuf's median patient age at 66, with 48% women.

In 2024, Dr. Yussuf wrote 56 Medicare Part D claims for 21 patients. 89% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $113 in total drug cost. In 2018, CMS named 28 claims across 2 drugs.

Dr. Yussuf accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Yussuf from 2 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 100% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $98.